Dr. Nagashree Seetharamu MD
Hematologist-Oncologist | Hematology & Oncology
26821 80th Ave Glen Oaks NY, 11004About
Dr. Nagashree Seetharamu is a hematologist oncologist practicing in Glen Oaks, NY. Dr. Seetharamu specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Vijayanagara Institute of Medical Sciences
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Internal MedicineAmerican Board of Internal MedicineABIM- 2006
Provider Details
Professional Memberships
- Member AMERICAN COLLEGE OF PHYSICIANS ASSO. MEMBER
- Member AMERICAN SOCIETY OF HEMATOLOGY ASSO.
Fellowships
- NYU School of Medicine (Hematology Oncology), Clinical Fellowships 2006
Dr. Nagashree Seetharamu MD's Practice location
Dr. Nagashree Seetharamu MD's reviews
Write ReviewPatient Experience with Dr. Seetharamu
Recommended Articles
- What are the Stages of Multiple Myeloma?
This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...
- 7-year-old with Lymphoma Joins and Inspires Lacrosse Team
Sports have a way of bringing together families, strangers, and communities. All over the world people celebrate games and competitions and use them to lift people’s spirits and strengthen bonds. Sporting events are also frequently used to raise awareness about important causes, whether locally or...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
- Teen Treated for Lymphoma to Play College Baseball
Whether it’s the Dodgers or the Red Sox or the local high school team, they’re called ‘the boys of summer’.While summer is when the teams begin competitive play, they are very much the boys of spring as well.The temperature might be cool, but the air is sweet with promise.The players pull...